← All stories
Markets

Explore Nuformix (LSE:NFX): What Is Driving Fresh Interest?

1 source ·1 article ·2h ago

Highlights Nuformix reports encouraging inhaled therapy study findings. Lung exposure data strengthens the development case for its lead programme. Upcoming scientific presentation may support licensing discussions. Nuformix has reported su…

Covered by 1 outlet

All coverage · 1 article